American Well Corp (AMWL): Nasdaq/NYSE listing notice — American Well (AMWL) receives NYSE delisting notice for non-compliance with $1 minimum bid price

American Well Corp

On April 2, 2024, received NYSE notice that average closing price of AMWL common stock was below $1 per share over 30 consecutive trading-days.
No immediate delisting; six-month cure period beginning April 2 to regain compliance.
Company plans to regain compliance through a reverse stock split, subject to board and stockholder approval at its 2024 annual meeting.
The notice does not affect business operations, SEC reporting obligations, or continued NYSE trading during cure period.

item 3.01 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

American Well Corp received a nyse noncompliance notice notice regarding minimum bid price (rules 802.01C).

Exchange: nyse
Notice: noncompliance notice
Deficiency: minimum bid price
Rules: 802.01C

Exact text from the filing

April 2, 2024, American Well Corporation (the “Company”) received a notice from the New York Stock Exchange (the “NYSE”) that the Company was not in compliance with the continued listing minimum price criteria set forth in Section 802.01C of the NYSE’s Listed Company Manual (“Section 802.01C”) because the average closing price of the Company’s Class A Common Stock (the “Common Stock”) was less than $1.00 per share over a consecutive 30 trading-day period. The notice has no immediate impact on the listing of the Common Stock on the NYSE, subject to the Company’s compliance with the NYSE’s other

View on SEC.gov

50 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

American Well Corp filing history →

Source: SEC EDGAR

accession 0000950170-24-041830

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.